BELITE BIO, INC (BLTE) Insider Trading -- Recent Executive & Director Transactions
5 insiders reported 177 Form 4 transactions for BELITE BIO, INC (BLTE) over the past 18 months (most recent 2026-10-05). Recent activity: Scholl Hendrik Peter (Chief Medical Officer) Sell 200 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 24 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 120 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 50 shares, Scholl Hendrik Peter (Chief Medical Officer) Sell 78 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 200 | $32,725 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 24 | $3,951 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 120 | $19,859 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 50 | $8,322 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 78 | $13,072 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 12 | $2,019 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 14 | $2,371 |
| 2026-10-05 | Scholl Hendrik Peter | Chief Medical Officer | Sell | 2 | $340 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 3,413 | $622,869 |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 1,633 | $294,201 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,587 | $468,877 |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 2,000 | $362,107 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 2,635 | $475,071 |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 2,000 | $364,985 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 4,955 | $908,228 |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,759 | $688,899 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,252 | $1.2M |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,569 | $658,744 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 4,593 | $851,286 |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,872 | $717,408 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 7,800 | $1.5M |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 4,600 | $857,187 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 6,200 | $1.2M |
| 2026-09-09 | Chuang Hao-Yuan | Chief Financial Officer | Sell | 3,900 | $729,942 |
| 2026-09-09 | Lin Yu-Hsin | Chief Executive Officer | Sell | 3,045 | $573,253 |
Source: SEC Form 4 filings · as of 2026-10-05